Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation.
about
Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridizationSporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma6-Bromoindirubin-3'oxime (BIO) decreases proliferation and migration of canine melanoma cell lines.Intratumoral injection of Clostridium novyi-NT spores induces antitumor responses.Hypoxia-Related Marker GLUT-1, CAIX, Proliferative Index and Microvessel Density in Canine Oral Malignant NeoplasiaBreed-predispositions to cancer in pedigree dogs.Synergistic targeted inhibition of MEK and dual PI3K/mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma.Immunohistochemical characteristics of normal canine eyes.Canine ocular neoplasia: a review.Immunohistochemical expression of MDR1-Pgp 170 in canine cutaneous and oral melanomas: pattern of expression and association with tumour location and phenotype.Non-ocular melanomas in cats: a retrospective study of 30 cases.Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.Transcriptome Analysis of Canine Cutaneous Melanoma and Melanocytoma Reveals a Modulation of Genes Regulating Extracellular Matrix Metabolism and Cell Cycle.Late prostatic metastasis of an uveal melanoma in a miniature Schnauzer dog.Intranasal melanoma treated with radiation therapy in three dogs.Canine melanoma diagnosis: RACK1 as a potential biological marker.Naturally occurring melanomas in dogs as models for non-UV pathways of human melanomas.Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.Pigmented tumors in fallow deer ( Dama dama): 11 cases.Cutaneous Chromatophoromas in Captive Snakes.Comparative Aspects of Canine Melanoma.Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas.Cutaneous iridophoroma in a Green iguana (Iguana iguana).Prognostic significance of Ki67 and its correlation with mitotic index in dogs with diffuse large B-cell lymphoma treated with 19-week CHOP-based protocol.Use of Oncept melanoma vaccine in 69 canine oral malignant melanomas in the UK.Primary corneal melanocytoma in a Collie.Congenital cutaneous melanoma in a dog.Alteration in E-cadherin/β-catenin expression in canine melanotic tumors.Biphasic malignant melanoma adenocarcinoma in the digit of a dog.Prolongation of survival of dogs with oral malignant melanoma treated by en bloc surgical resection and adjuvant CSPG4-antigen electrovaccination.Congenital amelanotic melanoma in a crossbred heifer calf.PDGFRs expression in dogs affected by malignant oral melanomas: correlation with prognosis.Immunoexpression of S100A4 in canine skin melanomas and correlation with histopathological parameters
P2860
Q33772550-2FC11D1D-218B-480B-AF63-95D690A42AF4Q33790743-1D196C45-DD27-4BC1-8D03-33F6824A22FEQ35033796-34104D09-7A20-494E-9BCB-A523F9D96751Q35446009-53BC5DA9-3D49-4996-9441-11C775DB104EQ35932515-CC2396F3-8705-48DC-8F3B-5345DA2187F8Q36857180-FC75F243-8AE8-4763-A314-EF8202A4F68BQ37462300-F76F5D2A-C5BB-4787-BDCF-B8B6DCD5463FQ37966669-054902BE-3D50-42C0-8F42-8DFDE019AA08Q38113307-AA4F44D0-38DE-473A-ABB2-433D2486596CQ39251469-E463661C-BC6A-490D-A5D0-B96DFA623D09Q40107598-FAE8EBB5-8A47-49E2-BF09-5C8BB2C44E7CQ40951477-36AD967C-D62E-432F-8B3A-D9723F0747ADQ41124685-2C0779F3-09D8-4B31-BD90-F491608BD412Q41834331-1E31C39C-9A24-4891-858C-9CC401E32D5AQ41990731-0A44CEE9-2F01-4F73-A400-DEB1190E0B11Q43648706-76F907F1-686A-41D5-9744-CE60D55A1123Q44414914-EFEFA0BA-F82D-4E6A-8E79-C3308238B3D2Q46004922-B1D8641E-7A05-4A8C-AECA-85492F31DF5BQ46372635-0B0E14A0-C497-401F-8A21-8A3823ADBB65Q46556936-46796C9A-56FD-4B7A-ACE8-EDB2B1F674C1Q46594568-9904488A-40E7-4051-B9FA-F03302F616AFQ47547587-FEBB4CDE-2694-4772-889E-8CCF302649F9Q50193904-2C2235A5-40F9-4964-9833-E9D14A170D6EQ50194860-B3FFF8CE-82C3-4E29-ACFA-90116E8E755CQ50949817-F5971E98-FEC8-4D4D-8E94-9BDA67481D08Q51108170-39DB647D-64AF-4F9A-9300-F85F0572B650Q51344893-4902FCC0-0B56-4379-8CA5-381110DD1F4FQ52628692-16AEB4D0-E40F-4C88-B77A-1730E6BAFB0DQ52735449-DE1BB5D3-8A69-420F-BE39-7ED41D7D7B08Q53106935-CD98905A-A93A-4048-B0BD-91BAD8F8AF92Q53625220-4C360B5C-1BFB-4188-AE34-313A5142074CQ54217776-8A3044A2-BD60-4EAB-B33B-7A7BFD239EC7Q57274745-E4C0EDC3-0DA9-438C-AAB9-71E70D25EAD6
P2860
Prognostic markers for canine melanocytic neoplasms: a comparative review of the literature and goals for future investigation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic markers for canine ...... oals for future investigation.
@en
Prognostic markers for canine ...... oals for future investigation.
@nl
type
label
Prognostic markers for canine ...... oals for future investigation.
@en
Prognostic markers for canine ...... oals for future investigation.
@nl
prefLabel
Prognostic markers for canine ...... oals for future investigation.
@en
Prognostic markers for canine ...... oals for future investigation.
@nl
P2093
P2860
P356
P1433
P1476
Prognostic markers for canine ...... oals for future investigation.
@en
P2093
B E Kitchell
D G Esplin
I L Bergin
P J Bergman
R C Smedley
W L Spangler
P2860
P356
10.1177/0300985810390717
P577
2011-01-01T00:00:00Z